Estadíos agudo, subagudo y crónico del ACV isquémico

Respuesta generada por Itaca · 3 fuentes · 20 de abril de 2026

Pregunta original

Describeme los estadíos agudo, subagudo y crónico de una persona con ACV isquémico

Summary

In ischemic stroke, “acute,” “subacute,” and “chronic” usually refer to time from symptom onset and to the evolving pathophysiology and clinical priorities. Most guidelines and major trials focus on the hyperacute/acute window (first hours–days) for reperfusion, the subacute period (days–weeks) for stabilization and early rehabilitation, and the chronic phase (weeks–months–years) for long-term secondary prevention and functional adaptation.[1]``[2] Below is a pragmatic, clinician-oriented description of each phase.


1. Acute Phase (hyperacute

  • acute)

Typical time frame

  • Hyperacute: 0–24 h from onset
  • Acute (hospital phase): ~0–7 days from onset (sometimes up to 14 days), assuming clinical stability[1]``[2].

Pathophysiology and brain tissue status

  • Sudden occlusion of a cerebral artery → ischemic core (irreversible) + penumbra (potentially salvageable).
  • Maximum benefit of reperfusion therapy is within the first hours:
    • IV thrombolysis with alteplase or tenecteplase typically within ≤4.5 h in eligible patients.[1]
    • Endovascular thrombectomy (EVT) for large vessel occlusion up to 6 h, and in selected cases up to 24 h based on perfusion imaging and criteria from DAWN and DEFUSE 3.[1]``[3]

Clinical priorities

  1. Fast recognition and reperfusion (time is brain)

    • Use of stroke code systems; immediate CT/CTA (± CTP) or MRI/MRA.
    • Decision on IV thrombolysis and/or EVT based on time, imaging, clinical severity (e.g., NIHSS), and contraindications.[1]``[3]
  2. Acute medical management and complication prevention

    • Maintain oxygenation, manage blood pressure according to reperfusion status (permissive hypertension if no thrombolysis/EVT; tighter control after).[1]``[2]
    • Control of glucose, temperature, and prevention of aspiration and pneumonia.
    • Early antiplatelet therapy (usually aspirin) after brain imaging rules out hemorrhage and outside thrombolysis window, per guideline recommendations; dual antiplatelet (aspirin + clopidogrel) in selected minor stroke/TIA and short term.[2]
    • Anticoagulation: avoided in the first hours for most, except specific indications (e.g., cerebral venous sinus thrombosis, mechanical valve). Atrial fibrillation–related strokes follow delayed anticoagulation algorithms (e.g., “1-3-6-12 day” rules depending on severity).[2]
  3. Early assessment of cause and risk factors

    • Initial workup for large artery atherosclerosis, cardioembolism, small vessel disease, rare causes (dissection, hypercoagulability, vasculitis).
    • Start of statin therapy (high-intensity) in atherosclerotic or presumed atherosclerotic ischemic strokes unless contraindicated.[2]
  4. Early rehabilitation and dysphagia/nutrition

    • Bedside swallow screen within first 24 h, early mobilization as soon as medically safe, initiation of physical, occupational, and speech therapy to prevent deconditioning and complications.[1]``[2]

2. Subacute Phase

Typical time frame

  • Approximately from the end of the acute hospital phase to ~3 months after the stroke.
  • Many authors and guidelines functionally define it as the period when the patient is medically stable but still undergoing significant spontaneous neurological recovery and active rehabilitation.[1]``[2]

Pathophysiology and recovery

  • Resolution of edema and penumbral tissue; reorganization of surviving neural networks and neuroplasticity are maximal in the first weeks to a few months.
  • Functional recovery curve is steepest in the first 3 months, and may extend (slower) up to 6 months and beyond.[1]``[2]

Clinical priorities

  1. Medical stabilization and optimization of secondary prevention

    • Fine-tuning antithrombotic regimen based on etiology (single antiplatelet vs short-term dual antiplatelet vs oral anticoagulation for AF or other cardioembolic sources).[2]
    • Aggressive risk factor control: blood pressure, lipids (statins, ± ezetimibe/PCSK9 in high-risk patients), glycemic control in diabetics, smoking cessation, weight management, sleep apnea evaluation.[2]
    • Completion of etiologic workup if not done acutely (echocardiography, extended Holter, carotid imaging, thrombophilia or vasculitis screening when indicated).
  2. Structured rehabilitation and functional recovery

    • Intensive, goal-directed, multidisciplinary rehab (physiatry, physical therapy, occupational therapy, speech therapy, neuropsychology).
    • Focus on: motor recovery, gait and balance, ADLs, aphasia, dysarthria, dysphagia, cognitive impairment, visual field deficits, neglect.
    • Exploits the window of heightened neuroplasticity; intensity and early initiation are associated with better outcomes, as supported by trials and rehabilitation guidelines.[1]``[2]
  3. Management of early post-stroke complications

    • Spasticity, shoulder subluxation and pain, neuropathic pain, urinary retention or incontinence, constipation, pressure ulcers, venous thromboembolism (with ongoing prophylaxis if needed).[1]``[2]
    • Mood disorders and cognitive impairment: screening and early treatment of post-stroke depression and anxiety, as these impact participation in rehabilitation and functional outcomes.
  4. Education and planning

    • Patient and family education about warning signs of recurrent stroke, medication adherence, lifestyle changes.
    • Planning for discharge destination: home with services vs inpatient rehab facility vs long-term care, depending on functional status and social support.

3. Chronic Phase

Typical time frame

  • Begins after ~3 months post-stroke and extends indefinitely (months to years).[1]``[2]
  • Neurological deficits tend to be more stable; further gains occur but usually more slowly and often via compensatory mechanisms.

Pathophysiology and long-term adaptations

  • Established infarct and gliosis; long-term cortical reorganization and behavioral adaptation.
  • Secondary complications of disability become prominent (chronic spasticity, contractures, osteoporosis, chronic pain, social and vocational impact).

Clinical priorities

  1. Long-term secondary prevention

    • Lifelong management of vascular risk factors:
      • Antithrombotic therapy:
        • Continued antiplatelet therapy for non-cardioembolic ischemic stroke (e.g., aspirin or clopidogrel monotherapy).[2]
        • Long-term oral anticoagulation for atrial fibrillation or other cardioembolic sources as indicated (DOACs or warfarin depending on context).[2]
      • Blood pressure control per hypertension guidelines (often target <130/80 mmHg in many patients, individualized).[2]
      • High-intensity statin and LDL-C lowering to targets recommended for secondary prevention; more intensive regimes in very high-risk patients.[2]
      • Lifestyle interventions (diet, physical activity, smoking cessation, weight and glycemic control).
  2. Long-term rehabilitation, disability management, and participation

    • Continued outpatient rehabilitation or community programs for residual deficits; task-specific training; assistive devices (orthoses, canes, wheelchairs).
    • Management of spasticity (physiotherapy, oral antispastic agents, botulinum toxin, intrathecal baclofen when appropriate).
    • Treatment of chronic pain, central post-stroke pain, and musculoskeletal problems.
    • Addressing participation: return to driving (where allowed), work, and social roles; assessment of capacity and workplace adaptations.
  3. Neuropsychiatric and cognitive sequelae

    • Persistent or late-onset depression, anxiety, emotional lability (pseudobulbar affect), and cognitive impairment or vascular dementia.
    • Need for routine screening, psychological/psychiatric interventions, and caregiver support. These factors significantly influence long-term quality of life and adherence.[1]``[2]
  4. Monitoring and follow-up

    • Regular follow-up with neurology/stroke clinic and primary care to monitor control of risk factors, medication tolerability, and functional status.
    • Reassessment if new neurological symptoms appear (to rule out recurrent stroke, TIA, seizures, or other pathology).

Practical Summary for Clinical Use

  • Acute (0–~7 days): Focus on rapid diagnosis, reperfusion (IVT/EVT), stabilization, prevention of early complications, initiation of secondary prevention, and early rehabilitation.[1]``[3]
  • Subacute (~1 week–3 months): Patient is medically more stable; emphasis on intensive, multidisciplinary rehabilitation, completion of etiologic workup, optimization of antithrombotic therapy and risk factor control, prevention and treatment of emerging complications, and discharge planning.[1]``[2]
  • Chronic (>3 months): Long-term secondary prevention, maintenance or further improvement of function, management of chronic deficits and neuropsychiatric sequelae, and maximization of independence and quality of life.[1]``[2]

These time windows are somewhat arbitrary and may overlap, but they provide a practical framework for organizing management priorities in ischemic stroke.


References (links as required by policy)

[1] 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack – Stroke. Available at: [1]

[2] 2021 ESO Guidelines on Secondary Prevention after Ischaemic Stroke or Transient Ischaemic Attack. European Stroke Journal. Available at: [2]

[3] Nogueira RG et al. DAWN Trial: Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. Available at: [3]

Fuentes

  1. https://www.ahajournals.org/doi/10.1161/STR.0000000000000375
  2. https://pubmed.ncbi.nlm.nih.gov/34414300
  3. https://pubmed.ncbi.nlm.nih.gov/29129157

Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.

¿Tienes una pregunta sobre tu propio caso? Itaca responde con fuentes en segundos.

Hacer una pregunta

Más preguntas sobre accidente cerebrovascular isquémico